About Dermala
Dermala is a Healthcare company based in San Diego (United States) founded in 2014. Developer of therapeutics to treat and prevent diseases associated with the skin microbiome dysbiosis. Dermala has raised $7.73 million across 2 funding rounds from investors including True Wealth Ventures, Seventure Partners and Cove Fund. Dermala offers products and services including SUPPLEMEANT to Be, SCANTILY Pad, OAT So Sweet, CLEANSE Forever, and Do Your TONE Thing. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Its legal entity is Dermala Inc. Its competitors include Revance Therapeutics, Synlogic Therapeutics and Pendulum; 3 of its 3 listed competitors have raised funding.
Company details
Dermala is a spinout from the University of California San Diego and JLABS incubator company. They are utilizing the human skin microbiome to develop treatments for skin diseases associated with the skin microbiome dysbiosis. In addition, Dermala is incorporating microbiome sequencing into the treatment decision-making process.
- Total Equity Funding$7.73M (USD)
in 2 rounds
- Latest Funding Round$6.73M (USD), Series A
Oct 2020
- InvestorsTrue Wealth Ventures
& 3 more
Products & Services of Dermala
Dermala offers a comprehensive portfolio of products and services, including SUPPLEMEANT to Be, SCANTILY Pad, OAT So Sweet, CLEANSE Forever, and Do Your TONE Thing.
Probiotic and vitamin supplement to fight acne internally.
Probiotic pads for external acne treatment and skin balance.
Probiotic moisturizer to soothe and prevent acne breakouts.
Gentle probiotic cleanser for daily acne-prone skin care.
Balancing toner to maintain skin microbiome and reduce acne.
Eco-friendly pads for applying acne treatments effectively.
Apps and channels of Dermala
its YouTube channel Dermala has 1.09K subscribers and 7 videos.
Videos from Dermala
The most watched videos on Dermala's YouTube channel, Dermala (1.09K subscribers). Click a video to play it here.
More on Dermala.
Funding Insights of Dermala
Dermala has successfully raised a total of $7.73M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $6.73 million completed in October 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.73M
- Total Rounds 2
- Last Round Series A — $6.73M
- First Round $1M
(Apr 2018)
- Investors Count 4
All 2 funding rounds of Dermala with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2020 | $6.73M | Series A | – | True Wealth Ventures, Johnson & Johnson Innovation | |
| Apr 2018 | $1M | Seed | – | – | – |
4 investors in total: 4 institutional.
Investors in Dermala
Dermala has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include True Wealth Ventures, Seventure Partners and Cove Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
True Wealth Ventures is focused on investing in women-led companies. | 2016 | truewealthvc.com | ||
Tech & Life Sciences focused stage agnostic VC firm investing in Europe, Asia & the US | seventure.fr | Paris, France | ||
Seed-stage venture capital funding is provided by Cove Fund. | 2021 | covefund.com | Irvine, United States | |
| jnjinnovation.com |
Investor details for Dermala
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Dermala
4 people are tracked at Dermala (4 in leadership).
| Name | Role | Group |
|---|---|---|
Alex Alim | CTO | Leadership |
Lada Rasochova | CEO | Leadership |
Michelle Kem | COO | Leadership |
Philip Dao | VP - Business Development Asia Pacific | Leadership |
Complete people profiles for Dermala
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Dermala
3 dated milestones of Dermala across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Dermala is founded.
- Funding First funding round of $1.0M.
- Funding Latest funding round, Series A, of $6.7M.
Competitors of Dermala
Dermala has 3 listed competitors in our database, 3 of them funded. They include Revance Therapeutics, Synlogic Therapeutics and Pendulum.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| revance.com | 2002 | Newark, United States | $154.56M | 597 | Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | |
| synlogictx.com | 2013 | Cambridge, United States | $34.4M | 85 | Engineered microbes are developed as programmable therapeutics for metabolic disorders. | |
| pendulumlife.com | 2012 | San Francisco, United States | $109.5M | 55 | Pendulum is focused on developing advanced probiotic solutions. |
Detailed competitors of Dermala
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Dermala
The website of Dermala (dermala.com) receives about 8.4K visits a month.
- Monthly visits8.4K
▲ 56.7% vs previous month
Websites whose visitors overlap most with Dermala. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| facerealityskincare.com | 100% | 72.7K | #417,625 | View details | |
porefavor.com | porefavor.com | 100% | #594,551 | – | |
| starface.world | 100% | 179.5K | #244,801 | View details | |
| clearwithin.com | 98% | 680.7K | #2,602,722 | View details | |
| clearstem.com | 98% | #180,335 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 21 similar websites and full traffic analytics for Dermala
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 21 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Dermala (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Dermala
Complete news archive for Dermala
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dermala
Dermala was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Dermala is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Dermala is a funded company, having raised a total of $7.73M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1M, raised on Apr 2018.
Dermala is a spinout from the University of California San Diego and JLABS incubator company. They are utilizing the human skin microbiome to develop treatments for skin diseases associated with the skin microbiome dysbiosis. In addition, Dermala is incorporating microbiome sequencing into the treatment decision-making process.
Dermala's top competitors include Revance Therapeutics, Pendulum and Synlogic Therapeutics.
Dermala offers SUPPLEMEANT to Be, SCANTILY Pad, OAT So Sweet, CLEANSE Forever, and 2 more products and services.
Dermala has 4 investors. Key investors include True Wealth Ventures, Seventure Partners, Cove Fund, and Johnson & Johnson Innovation.
Dermala operates through Dermala Inc..